iX Biopharma Ltd. announced the allotment and issuance of 80,885 new ordinary shares on Mar, 25 2026, following the exercise of warrants at 0.06 Singapore dollars per share.
The exercise lifts the company’s total issued share capital from 1,038,243,644 to 1,038,324,529 shares. The new shares are expected to begin trading on the Singapore Exchange on or around Mar, 27 2026.
To date, 7,565,084 warrants—13.15% of the total originally issued—have been exercised. A remaining 49,944,395 warrants, each with an exercise price of 0.06 Singapore dollars, will expire on Jul, 18 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.